May 1, 1980HeartOpen Access

Salbutamol in cardiogenic shock complicating acute myocardial infarction.

View Full Paper

Ask AI

Bookmark

Why the study?

Does intravenous salbutamol improve haemodynamics and survival in patients with cardiogenic shock complicating acute myocardial infarction?

Population

31 patients with cardiogenic shock complicating acute myocardial infarction

Design

Case_series

Follow-up

until hospital discharge

Authors

JDJ R DawsonUniversity of North Carolina at Chapel Hill PPP. A. Poole‐WilsonLung Institute GSG C SuttonEuroHealthNet

Discussion

Member takes

Implication

May support haemodynamic use of salbutamol in post-MI shock; hypothesis-generating and should not change practice.

Structured PICO

Does intravenous salbutamol improve haemodynamics and survival in patients with cardiogenic shock complicating acute myocardial infarction?

Population

31 patients with cardiogenic shock complicating acute myocardial infarction

Intervention

Intravenous salbutamol (13 microgram/min)

Outcome

Haemodynamic measurements (cardiac index, systemic vascular resistance, heart rate, pulmonary artery end-diastolic pressure) and survival to hospital dischargesurrogate

Intravenous salbutamol may improve haemodynamics through positive chronotropic action and afterload reduction in patients with cardiogenic shock complicating acute myocardial infarction.

Cite This Study

Dawson et al. (1980) studied this question.

synapsesocial.com/papers/6a897bfa65c8981d3ff7c294 https://doi.org/10.1136/hrt.43.5.523

View Full Paper

Ask AI

Bookmark

Salbutamol in cardiogenic shock complicating acute myocardial infarction.

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Salbutamol in cardiogenic shock complicating acute myocardial infarction.

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider